VIP (5mg) refers to Vasoactive Intestinal Peptide, a naturally occurring neuropeptide and signaling molecule studied for its role in immune modulation, anti-inflammatory activity, and cellular communication. VIP interacts with multiple receptor systems (VPAC1 and VPAC2), and has been researched for its potential effects on respiratory function, inflammation balance, and neurological signaling.
This guide outlines a general reconstitution and subcutaneous research use format commonly used in peptide studies.
Concise summary of general research use patterns.
General research-oriented approach for the 5 mg vial format.
Vasoactive Intestinal Peptide (VIP) is a 28-amino-acid neuropeptide that functions as both a neurotransmitter and immunomodulatory signaling molecule. It binds primarily to VPAC1 and VPAC2 receptors, activating adenylate cyclase and increasing intracellular cyclic AMP (cAMP).
Through these pathways, VIP is involved in regulating smooth muscle relaxation, vasodilation, immune cell activity, and inflammatory cytokine production. Research suggests it may help shift immune response balance toward anti-inflammatory signaling while also playing roles in pulmonary function, gut-brain axis communication, and neuroprotection.
Findings based on preclinical and investigational research.
Potential Benefits:
Possible Side Effects: